Avenue Therapeutics, Inc. announced the appointment of Joseph Vazzano as Vice President of Finance and Corporate Controller (principal financial and accounting officer). Mr. Vazzano will assume the responsibilities previously held by Avenue's Interim Chief Financial Officer, David Horin. Mr. Vazzano joins Avenue from Intercept Pharmaceuticals, Inc., where he served as Assistant Corporate Controller and oversaw the expansion of the company's finance and accounting department during its transition from development-stage to a fully integrated commercial organization.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.81 USD | +2.14% | -3.54% | -68.45% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-68.45% | 3.58M | |
+9.58% | 115B | |
+12.41% | 107B | |
-3.26% | 21.6B | |
-12.38% | 22.31B | |
-5.71% | 19.19B | |
-3.35% | 18.23B | |
-38.57% | 17.62B | |
+7.51% | 14.26B | |
+35.67% | 12.37B |
- Stock Market
- Equities
- ATXI Stock
- News Avenue Therapeutics, Inc.
- Avenue Therapeutics, Inc. Announces Executive Changes